Research on increased menstrual bleeding in Unani Medicine

Comparative study of Tukhm-e -Bartang with Tranexamic acid in Kathrat-i-Tamth (Heavy Menstrual Bleeding) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/060987

Enrollment

Registered

2024-01-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

Intervention1: Safoof(powder) of Tukhm-e-Bartang: Orally thrice daily for 5 days for 3 consecutive cycles (From D1 to D5 of menstruation) Control Intervention1: Tranexamic acid 500mg: Orally thrice da

Eligibility

Inclusion criteria

Inclusion criteria: Patients of reproductive age group 18- 45yrs. Patients with regular menstrual cycle with amount of flow more than 80ml and/or duration of flow more than 7 days. Patients with pelvic pathology like Uterine fibroids less than 3 cms and adenomyosis. Patients with IUCD.

Exclusion criteria

Exclusion criteria: Patients with (uncontrolled diabetes mellitus, uncontrolled hypertension, thyroid dysfunction). Severe anemia with Hb% less than 7mg/dl. Uterine fibroids more than 3cms. Patients on OCP’S, or any other hormonal therapy. Patients with blood dyscrasias and malignancy.

Design outcomes

Primary

Measure	Time frame
Decrease in menstrual pictogram score.Timepoint: Before and after mensturation for 3 months.	—

Secondary

Measure	Time frame
Improvement in SF-12 scale for quality of life. Improvement in Hb%. Timepoint: Before and after mensuration for 3 months.	—

Countries

India

Contacts

Public ContactDr Aisha Anjum A

Government Unani Medical College and Hospital

dr.aanjuma@gmail.com8951592300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026